RUNX2 and breast carcinoma: Consistent with that report, the depletion of RUNX2 by siRNA inhibited proliferation, as determined by a 5-ethynyl-20-deoxyuridine (EdU) assay, in MDA-MB-231 and SUM159 breast cancer cells.